Key points The presence of cachexia is being recognised to have a negative impact on surgery and immune therapy. In the absence of pharmacological therapies multimodal treatments, such as nutrition and exercise, should be used [more]
A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European Cancer Organisation, Brussels on 7th October.1 The [more]
In addition to previously reported survival benefits, the taxane cabazitaxel improved quality of life in patients with advanced metastatic prostate cancer compared to the androgen signalling targeted inhibitors abiraterone and enzalutamide, reports the latest analysis [more]
For the first time, an investigator initiated phase 1b study tested the combination of the PARP inhibitor olaparib, and the AKT inhibitor capivasertib, and showed this combination was well tolerated and achieved durable responses in [more]
There are over two million new cases of breast cancer a year in the world and 0.6 million deaths. About a third of all early breast cancer cases will become metastatic even with the best [more]
A joint ESO-SPCC task-force met to design a strategy to help different actors involved in cancer care to optimise patient journey, tackling challenges from different points of view. “I think the focus here is not [more]
A quarter of cancer patients who could benefit from radiotherapy do not receive it. As head of policy and partnerships, Chiara Gasparotto is positioning the European Society for Radiotherapy to make the case for better [more]